BioSpace News Archive

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines to create a new generation of transformative medicines for patients, announced its participation in upcoming investor conferences

- Amgen (NASDAQ:AMGN) and Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for omecamtiv mecarbil, a novel selective cardiac myosin activator, also known as a cardiac myotrope, 1 being developed for the potential treatment of chronic heart failure with reduced ejection fraction (HFrEF). Fast Track designation may p

vybe urgent care, with 11 centers in the greater Philadelphia market, is pleased to offer COVID-19 serological antibody testing to help patients determine if they’ve already been exposed to the coronavirus.

With efforts to help essential businesses that have remained open and those that are gearing up to re-open, ProTech Biohazard Remediation has a solution to help business get back on track safely.

Amgen (NASDAQ:AMGN) and Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for omecamtiv m

Sales Revenue Doubled Versus Prior Year Quarter Strong Gross Margin And Earnings Growth From Improved Sales Mix And Lower Costs Significantly Improved Balance Sheet From Reduced Debt

Zymeworks Inc., a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, is pleased to announce the detailed voting results on the items of business considered at its Annual General Meeting of Shareholders held on May 7, 2020.

Results presented virtually via Heart Rhythm 365 Platform; study met primary effectiveness endpoint of superiority in favor of the hybrid Convergent procedure MASON, Ohio--( BUSINESS WIRE )-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced the results from the CONVERGE IDE clinical trial. This first-of-its-kind trial, designed to demonstrate supe

North American Partners in Anesthesia, one of the leading single-specialty anesthesia and perioperative management companies in the US, welcomes our new clinical partner, Waterbury Hospital.

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced its Annual General Meeting (“AGM”) will be held on May 15, 2020 at 10:00 a.m. ET. Due to the impact of the COVID-19 pandemic, the meeting will be held virtually. Shareholders will not be able to attend the AGM in-person at a physical location. Ho